Drug-resistant pathogens drive a more concerted effort against microbial contamination

摘要

The threat of "superbugs" and the frustrating prevalence of hospital-acquired (nosocomial) infections are spurring stepped-up vigilance for microbial contamination in health-care settings. In addition, pharmaceutical and biopharmaceutical manufacturing companies are being tasked not only to develop therapies for these infections, but also to re-evaluate and strengthen their efforts at preventing them, and are finding success in applying risk-based approaches to contamination control in their processes and equipment.